ID   SERA5_PLAFG             Reviewed;         989 AA.
AC   P69192; P13823;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   07-APR-2021, entry version 68.
DE   RecName: Full=Serine-repeat antigen protein 5 {ECO:0000305};
DE            EC=3.4.22.- {ECO:0000250|UniProtKB:Q9TY95};
DE   AltName: Full=111 kDa antigen;
DE   AltName: Full=Serine protease SERA5 {ECO:0000305};
DE   AltName: Full=p126;
DE   Contains:
DE     RecName: Full=p47 {ECO:0000303|PubMed:1501648};
DE     AltName: Full=SER36 {ECO:0000250|UniProtKB:P69193};
DE   Contains:
DE     RecName: Full=p56 {ECO:0000303|PubMed:1501648};
DE   Contains:
DE     RecName: Full=p50 {ECO:0000303|PubMed:1501648};
DE   Contains:
DE     RecName: Full=p18 {ECO:0000303|PubMed:1501648};
DE   Contains:
DE     RecName: Full=p25n {ECO:0000250|UniProtKB:Q9TY95};
DE   Contains:
DE     RecName: Full=p25c {ECO:0000250|UniProtKB:Q9TY95};
DE   Flags: Precursor;
GN   Name=SERA5 {ECO:0000303|PubMed:2651911};
OS   Plasmodium falciparum (isolate FCR-3 / Gambia).
OC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX   NCBI_TaxID=5838;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2651911; DOI=10.1016/0166-6851(89)90037-6;
RA   Li W.-B., Bzik D.J., Horii T., Inselburg J.;
RT   "Structure and expression of the Plasmodium falciparum SERA gene.";
RL   Mol. Biochem. Parasitol. 33:13-26(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2847041; DOI=10.1016/0166-6851(88)90097-7;
RA   Bzik D.J., Li W.-B., Horii T., Inselburg J.;
RT   "Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium
RT   falciparum determined from cloned cDNA.";
RL   Mol. Biochem. Parasitol. 30:279-288(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-362.
RC   STRAIN=FCR-3 / Gambia;
RX   PubMed=2456465; DOI=10.1016/0166-6851(88)90127-2;
RA   Horii T., Bzik D.J., Inselburg J.;
RT   "Characterization of antigen-expressing Plasmodium falciparum cDNA clones
RT   that are reactive with parasite inhibitory antibodies.";
RL   Mol. Biochem. Parasitol. 30:9-18(1988).
RN   [4]
RP   PROTEIN SEQUENCE OF 23-27; 383-392 AND 879-883, DEVELOPMENTAL STAGE, AND
RP   PROTEOLYTIC CLEAVAGE.
RX   PubMed=1501648; DOI=10.1016/0166-6851(92)90010-h;
RA   Debrabant A., Maes P., Delplace P., Dubremetz J.F., Tartar A., Camus D.;
RT   "Intramolecular mapping of Plasmodium falciparum P126 proteolytic fragments
RT   by N-terminal amino acid sequencing.";
RL   Mol. Biochem. Parasitol. 53:89-95(1992).
RN   [5]
RP   SIMILARITY TO THIOL PROTEASES OF A DOMAIN.
RX   PubMed=2671749; DOI=10.1038/340604a0;
RA   Higgins D.G., McConnell D.J., Sharp P.M.;
RT   "Malarial proteinase?";
RL   Nature 340:604-604(1989).
RN   [6]
RP   SIMILARITY TO THIOL PROTEASES OF A DOMAIN.
RX   PubMed=2682262; DOI=10.1038/342132b0;
RA   Eakin A.E., Higaki J.N., McKerrow J.H., Craik C.S., Mottram J.C.,
RA   Coombs G.H., North M.J.;
RT   "Cysteine or serine proteinase?";
RL   Nature 342:132-132(1989).
RN   [7]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND BIOTECHNOLOGY.
RX   PubMed=12244052; DOI=10.1074/jbc.m207145200;
RA   Aoki S., Li J., Itagaki S., Okech B.A., Egwang T.G., Matsuoka H.,
RA   Palacpac N.M., Mitamura T., Horii T.;
RT   "Serine repeat antigen (SERA5) is predominantly expressed among the SERA
RT   multigene family of Plasmodium falciparum, and the acquired antibody titers
RT   correlate with serum inhibition of the parasite growth.";
RL   J. Biol. Chem. 277:47533-47540(2002).
RN   [8] {ECO:0007744|PDB:2MUG}
RP   STRUCTURE BY NMR OF 901-920.
RX   PubMed=16126320; DOI=10.1016/j.biochi.2005.07.006;
RA   Patarroyo M.E., Salazar L.M., Cifuentes G., Lozano J.M., Delgado G.,
RA   Rivera Z., Rosas J., Vargas L.E.;
RT   "Protective cellular immunity against P. falciparum malaria merozoites is
RT   associated with a different P7 and P8 residue orientation in the MHC-
RT   peptide-TCR complex.";
RL   Biochimie 88:219-230(2006).
CC   -!- FUNCTION: Plays an essential role during the asexual blood stage
CC       development by controlling the kinetics of merozoite egress from host
CC       erythrocytes (By similarity). Specifically, prevents premature rupture
CC       of the parasitophorous vacuole and host erythrocyte membranes (By
CC       similarity). {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- FUNCTION: [p47]: May prevent merozoite phagocytosis by host monocytes
CC       via interaction with host VTN at the merozoite surface (By similarity).
CC       Plays a role in parasite growth (PubMed:12244052).
CC       {ECO:0000250|UniProtKB:P69193, ECO:0000269|PubMed:12244052}.
CC   -!- SUBUNIT: May interact (via C-terminus) with PTKL (via SAM domain).
CC       {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- SUBUNIT: [p47]: Interacts (via C-terminus) with human VTN (via
CC       hemopexin repeat 2); may form heterotetramers of two VTN and SERA5 P47
CC       heterodimers; the interaction may protect merozoites from phagocytosis
CC       by host monocytes; VTN glycosylation appears to be dispensable for the
CC       interaction. {ECO:0000250|UniProtKB:P69193}.
CC   -!- SUBUNIT: [p50]: Monomer. Interacts with kinase CPK1/CDPK1 at the
CC       schizont stage. {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- SUBCELLULAR LOCATION: [Serine-repeat antigen protein 5]:
CC       Parasitophorous vacuole {ECO:0000250|UniProtKB:Q9TY95}. Note=Secreted
CC       in large amount into the parasitophorous vacuole.
CC       {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- SUBCELLULAR LOCATION: [p18]: Secreted {ECO:0000250|UniProtKB:P69193}.
CC       Note=Secreted during merozoite egress from erythrocytes.
CC       {ECO:0000250|UniProtKB:P69193}.
CC   -!- SUBCELLULAR LOCATION: [p25n]: Secreted {ECO:0000250|UniProtKB:Q9TY95}.
CC       Note=Secreted during merozoite egress from erythrocytes.
CC       {ECO:0000250|UniProtKB:P69193}.
CC   -!- SUBCELLULAR LOCATION: [p25c]: Secreted {ECO:0000250|UniProtKB:P69193}.
CC       Note=Secreted during merozoite egress from erythrocytes.
CC       {ECO:0000250|UniProtKB:P69193}.
CC   -!- SUBCELLULAR LOCATION: [p47]: Secreted {ECO:0000250|UniProtKB:P69193}.
CC       Cell membrane {ECO:0000250|UniProtKB:Q9TY95}; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:Q9TY95}; Extracellular side
CC       {ECO:0000250|UniProtKB:P69193}. Note=Secreted during merozoite egress
CC       from erythrocytes (By similarity). Colocalizes at the merozoite surface
CC       with human VTN (By similarity). {ECO:0000250|UniProtKB:P69193,
CC       ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- SUBCELLULAR LOCATION: [p50]: Secreted {ECO:0000250|UniProtKB:Q9TY95}.
CC       Note=Secreted during egress from host erythrocytes.
CC       {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- SUBCELLULAR LOCATION: [p56]: Secreted {ECO:0000250|UniProtKB:Q9TY95}.
CC       Note=Secreted during egress from host erythrocytes.
CC       {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during parasite asexual blood stages,
CC       specifically at the late trophozoite and schizont stages (at protein
CC       level). {ECO:0000269|PubMed:12244052, ECO:0000269|PubMed:1501648}.
CC   -!- PTM: [p50]: Phosphorylation by CPK1/CDPK1 increases SERA5 protease
CC       activity towards a synthetic peptide in vitro.
CC       {ECO:0000250|UniProtKB:Q9TY95}.
CC   -!- PTM: Just prior to merozoite egress from host erythrocytes,
CC       proteolytically cleaved into multiple fragments (PubMed:1501648).
CC       Cleaved by SUB1 into p47 and p73, p73 is further cleaved by SUB1 into
CC       p56 and p18 and p56 is further processed into p50 by an unidentified
CC       protease (PubMed:1501648). p47 remains covalently associated with p18
CC       via disulfide bond (By similarity). p47 can be processed into p25n and
CC       p25c by SUB1 (By similarity). p25c and p25n remain associated with p18
CC       (By similarity). Proteolytic processing is essential for merozoite
CC       egress from host erythrocytes (By similarity). The cleavage of the
CC       propeptide to produce p50 is necessary for protease activity and to
CC       promote merozoite egress (By similarity).
CC       {ECO:0000250|UniProtKB:Q9TY95, ECO:0000269|PubMed:1501648}.
CC   -!- BIOTECHNOLOGY: [p47]: Potential candidate for the development of
CC       parasite blood stage vaccines (PubMed:12244052). In vitro and in vivo,
CC       induces antibodies capable of inhibiting parasite growth
CC       (PubMed:12244052). {ECO:0000269|PubMed:12244052}.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -!- CAUTION: In contrast to other serine-repeat antigen proteins (SERA) of
CC       the peptidase C1 family, contains a serine residue at the position of
CC       the canonical catalytic cysteine and has been shown to lack protease
CC       activity (By similarity). However, other studies show that it has
CC       protease activity towards synthetic peptides in vitro (By similarity).
CC       {ECO:0000250|UniProtKB:Q9TY95}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04000; AAA16791.1; -; Genomic_DNA.
DR   EMBL; X06427; CAA29734.1; -; mRNA.
DR   EMBL; J03993; AAA29763.1; -; mRNA.
DR   EMBL; M21323; AAA29488.1; -; mRNA.
DR   PIR; A54505; A54505.
DR   PIR; A54512; A54512.
DR   PDB; 2MUG; NMR; -; A=901-920.
DR   PDBsum; 2MUG; -.
DR   BMRB; P69192; -.
DR   SMR; P69192; -.
DR   MEROPS; C01.984; -.
DR   PRIDE; P69192; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020003; C:symbiont-containing vacuole; IEA:UniProtKB-SubCell.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Hydrolase; Malaria; Membrane; Phosphoprotein; Protease;
KW   Secreted; Signal; Thiol protease; Zymogen.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   CHAIN           17..989
FT                   /note="Serine-repeat antigen protein 5"
FT                   /id="PRO_0000026481"
FT   CHAIN           23..382
FT                   /note="p47"
FT                   /evidence="ECO:0000269|PubMed:1501648"
FT                   /id="PRO_0000450191"
FT   CHAIN           23..184
FT                   /note="p25n"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT                   /id="PRO_0000450192"
FT   CHAIN           185..382
FT                   /note="p25c"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT                   /id="PRO_0000450193"
FT   CHAIN           383..878
FT                   /note="p56"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT                   /id="PRO_0000450194"
FT   CHAIN           383..834
FT                   /note="p50"
FT                   /evidence="ECO:0000269|PubMed:1501648"
FT                   /id="PRO_0000450195"
FT   PROPEP          835..878
FT                   /note="Inhibition peptide"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT                   /id="PRO_0000450196"
FT   CHAIN           879..989
FT                   /note="p18"
FT                   /evidence="ECO:0000269|PubMed:1501648"
FT                   /id="PRO_0000450197"
FT   REGION          208..245
FT                   /note="Interaction with PTKL"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   REGION          365..382
FT                   /note="Interaction with host VTN"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   REGION          577..802
FT                   /note="Thiol protease-like"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   COMPBIAS        46..87
FT                   /note="Ser-rich"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        189..227
FT                   /note="Poly-Ser"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        754
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10089"
FT   ACT_SITE        779
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10090"
FT   SITE            184..185
FT                   /note="Cleavage; by SUB1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   SITE            382..383
FT                   /note="Cleavage; by SUB1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   SITE            588
FT                   /note="Ancestral active site"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   SITE            834..835
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   SITE            878..879
FT                   /note="Cleavage; by SUB1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   MOD_RES         541
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   MOD_RES         858
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   CARBOHYD        168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        310
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        820
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        437..489
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   DISULFID        559..564
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   DISULFID        573..602
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   DISULFID        585..628
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   DISULFID        619..664
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   DISULFID        747..801
FT                   /evidence="ECO:0000250|UniProtKB:Q9TY95"
FT   VARIANT         178..191
FT                   /note="Missing (in an allele)"
FT   CONFLICT        8
FT                   /note="F -> L (in Ref. 3; AAA29488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        44
FT                   /note="A -> T (in Ref. 3; CAA29734/AAA29488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        356..362
FT                   /note="EKENKND -> KKKKKGI (in Ref. 3; CAA29734)"
FT                   /evidence="ECO:0000305"
FT   HELIX           902..919
FT                   /evidence="ECO:0007744|PDB:2MUG"
SQ   SEQUENCE   989 AA;  111095 MW;  E732960770C15F52 CRC64;
     MKSYISLFFI LCVIFNKNVI KCTGESQTGN TGGGQAGNTV GDQAGSTGGS PQGSTGASQP
     GSSEPSNPVS SGHSVSTVSV SQTSTSSEKQ DTIQVKSALL KDYMGLKVTG PCNENFIMFL
     VPHIYIDVDT EDTNIELRTT LKETNNAISF ESNSGSLEKK KYVKLPSNGT TGEQGSSTGT
     VRGDTEPISD SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS SSSSSESLPA NGPDSPTVKP
     PRNLQNICET GKNFKLVVYI KENTLIIKWK VYGETKDTTE NNKVDVRKYL INEKETPFTS
     ILIHAYKEHN GTNLIESKNY ALGSDIPEKC DTLASNCFLS GNFNIEKCFQ CALLVEKENK
     NDVCYKYLSE DIVSNFKEIK AETEDDDEDD YTEYKLTESI DNILVKMFKT NENNDKSELI
     KLEEVDDSLK LELMNYCSLL KDVDTTGTLD NYGMGNEMDI FNNLKRLLIY HSEENINTLK
     NKFRNAAVCL KNVDDWIVNK RGLVLPELNY DLEYFNEHLY NDKNSPEDKD NKGKGVVHVD
     TTLEKEDTLS YDNSDNMFCN KEYCNRLKDE NNCISNLQVE DQGNCDTSWI FASKYHLETI
     RCMKGYEPTK ISALYVANCY KGEHKDRCDE GSSPMEFLQI IEDYGFLPAE SNYPYNYVKV
     GEQCPKVEDH WMNLWDNGKI LHNKNEPNSL DGKGYTAYES ERFHDNMDAF VKIIKTEVMN
     KGSVIAYIKA ENVMGYEFSG KKVQNLCGDD TADHAVNIVG YGNYVNSEGE KKSYWIVRNS
     WGPYWGDEGY FKVDMYGPTH CHFNFIHSVV IFNVDLPMNN KTTKKESKIY DYYLKASPEF
     YHNLYFKNFN VGKKNLFSEK EDNENNKKLG NNYIIFGQDT AGSGQSGKES NTALESAGTS
     NEVSERVHVY HILKHIKDGK IRMGMRKYID TQDVNKKHSC TRSYAFNPEN YEKCVNLCNV
     NWKTCEEKTS PGLCLSKLDT NNECYFCYV
//
